Kalytera Therapeutics

Pharmaceuticals

Active Multinational Qatsrin, United States Founded 2014

Kalytera Therapeutics Inc is a clinical-stage pharmaceutical company developing next-generation cannabinoid therapeutics. Kalytera develops novel cannabinoid medicines for a range of medical needs with an initial focus on graft-versus-host disease (GvHD). Kalytera also develops a new class of proprietary cannabidiol (CBD) therapeutics. Kalytera acquired its…

Employees6
Founded2014
HQQatsrin, United States
Confidence56